Current Status of Clostridium difficile Infection Epidemiology

The dramatic changes in the epidemiology of Clostridium difficile infection (CDI) during recent years, with increases in incidence and severity of disease in several countries, have made CDI a global public health challenge. Increases in CDI incidence have been largely attributed to the emergence of a previously rare and more virulent strain, BI/NAP1/027. Increased toxin production and high-level resistance to fluoroquinolones have made this strain a very successful pathogen in healthcare settings. In addition, populations previously thought to be at low risk are now being identified as having severe CDI. Recent genetic analysis suggests that C. difficile has a highly fluid genome with multiple mechanisms to modify its content and functionality, which can make C. difficile adaptable to environmental changes and potentially lead to the emergence of more virulent strains. In the face of these changes in the epidemiology and microbiology of CDI, surveillance systems are necessary to monitor trends and inform public health actions.

[1]  C. Kelly,et al.  Clostridium difficile--more difficult than ever. , 2008, The New England journal of medicine.

[2]  C. Record,et al.  Incidence and origin of Clostridium difficile in neonates , 1984, Journal of clinical microbiology.

[3]  H Humphreys,et al.  Prevalence surveys of healthcare-associated infections: what do they tell us, if anything? , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[4]  L. Peterson,et al.  Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. , 1992, The Journal of infectious diseases.

[5]  Mark Miller,et al.  Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  J. Cavanaugh,et al.  Trends in Clostridium difficile Infection among Peripartum Women , 2010, Infection Control & Hospital Epidemiology.

[7]  L. Peterson,et al.  Molecular epidemiology of Clostridium difficile over the course of 10 years in a tertiary care hospital. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  J. Gerberding,et al.  Severe Clostridium difficile-associated disease in populations previously at low risk--four states, 2005. , 2005, MMWR. Morbidity and mortality weekly report.

[9]  A. Goorhuis,et al.  Decrease of hypervirulent Clostridium difficile PCR ribotype 027 in the Netherlands. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[10]  D. Anderson,et al.  Comparison of the Burdens of Hospital-Onset, Healthcare Facility-Associated Clostridium difficile Infection and of Healthcare-Associated Infection due to Methicillin-Resistant Staphylococcus aureus in Community Hospitals , 2011, Infection Control & Hospital Epidemiology.

[11]  T. Horan,et al.  Recommendations for Surveillance of Clostridium difficile–Associated Disease , 2007, Infection Control & Hospital Epidemiology.

[12]  S. Vindigni,et al.  Clostridium difficile Infections among Hospitalized Children, United States, 1997–2006 , 2010, Emerging infectious diseases.

[13]  L. McDonald,et al.  Clostridium difficile Infection Among Children With Cancer , 2011, The Pediatric infectious disease journal.

[14]  Myrna Dyck,et al.  Population-Based Surveillance of Clostridium difficile Infection in Manitoba, Canada, by Using Interim Surveillance Definitions , 2009, Infection Control & Hospital Epidemiology.

[15]  C. Donskey,et al.  Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  T. Eckmanns,et al.  Clostridium difficile Surveillance Trends, Saxony, Germany , 2008, Emerging infectious diseases.

[17]  E. Kuijper,et al.  Emergence of Clostridium difficile-associated disease in North America and Europe. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[18]  J. R. Scotti,et al.  Available From , 1973 .

[19]  B. Wren,et al.  Comparative analysis of BI/NAP1/027 hypervirulent strains reveals novel toxin B-encoding gene (tcdB) sequences. , 2008, Journal of medical microbiology.

[20]  L. Mascola,et al.  Increase in Clostridium difficile–related Mortality Rates, United States, 1999–2004 , 2007, Emerging infectious diseases.

[21]  M. Samore,et al.  Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea , 1998, The Lancet.

[22]  J. Pemán,et al.  Epidemiology of invasive fungal infections due to Aspergillus spp. and Zygomycetes , 2006 .

[23]  M. Quail,et al.  Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium , 2009, Genome Biology.

[24]  L. McDonald,et al.  Bench-to-bedside review: Clostridium difficile colitis , 2008, Critical care.

[25]  R. Barton,et al.  Clindamycin-associated colitis. A prospective study. , 1974, Annals of internal medicine.

[26]  M. Wilcox,et al.  A case-control study of community-associated Clostridium difficile infection. , 2008, The Journal of antimicrobial chemotherapy.

[27]  K. Welch,et al.  Evaluation of Hospital Room Assignment and Acquisition of Clostridium difficile Infection , 2011, Infection Control & Hospital Epidemiology.

[28]  M. Owings,et al.  Clostridium difficile Infection in Patients Discharged from US Short-stay Hospitals, 1996–2003 , 2006, Emerging Infectious Diseases.

[29]  D. Gerding,et al.  Clostridium difficile--associated diarrhea. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  Ellen Jo Baron,et al.  Impact of Strain Type on Detection of Toxigenic Clostridium difficile: Comparison of Molecular Diagnostic and Enzyme Immunoassay Approaches , 2010, Journal of Clinical Microbiology.

[31]  J. Bartlett,et al.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. , 1978, The New England journal of medicine.

[32]  M. Zilberberg.  Clostridium difficile Infections among Hospitalized Children , 2010 .

[33]  A. Charlett,et al.  Comparison of Nine Commercially Available Clostridium difficile Toxin Detection Assays, a Real-Time PCR Assay for C. difficile tcdB, and a Glutamate Dehydrogenase Detection Assay to Cytotoxin Testing and Cytotoxigenic Culture Methods , 2009, Journal of Clinical Microbiology.

[34]  C. Gidengil,et al.  Epidemiology and Risk Factors for Clostridium difficile Infection in Children , 2011, The Pediatric infectious disease journal.

[35]  R. Campbell,et al.  Clostridium difficile Infection in Ohio Hospitals and Nursing Homes During 2006 , 2009, Infection Control & Hospital Epidemiology.

[36]  D. Gerding,et al.  Decrease in Nosocomial Clostridium difficileAssociated Diarrhea by Restricting Clindamycin Use , 1994, Annals of Internal Medicine.

[37]  J. Tokars,et al.  Automated Surveillance of Clostridium difficile Infections Using BioSense , 2011, Infection Control & Hospital Epidemiology.

[38]  Jiaquan Xu,et al.  Deaths: preliminary data for 2008. , 2010, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[39]  Stuart Johnson,et al.  An epidemic, toxin gene-variant strain of Clostridium difficile. , 2005, The New England journal of medicine.

[40]  W. Stamm,et al.  Nosocomial acquisition of Clostridium difficile infection. , 1989, The New England journal of medicine.

[41]  I. C. Hall,et al.  INTESTINAL FLORA IN NEW-BORN INFANTS: WITH A DESCRIPTION OF A NEW PATHOGENIC ANAEROBE, BACILLUS DIFFICILIS , 1935 .

[42]  Jon Brazier,et al.  Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe , 2005, The Lancet.

[43]  L. McDonald,et al.  Clostridium difficile Infections among Hospitalized Children, United States, 1997–2006 , 2010, Emerging infectious diseases.

[44]  E. Kuijper,et al.  Clostridium difficile infection in Europe: a hospital-based survey , 2011, The Lancet.